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Abstract
Resilience has been related to improved physical and mental health, and is thought to improve with age. No studies have 
explored the relationship between resilience, ageing with HIV, and well-being. A cross sectional observational study per-
formed on UK HIV positive (N = 195) and HIV negative adults (N = 130). Associations of both age and ‘time diagnosed 
with HIV’ with resilience (RS-14) were assessed, and the association of resilience with depression, anxiety symptoms 
(PHQ-9 and GAD-7), and problems with activities of daily living (ADLs) (Euroqol 5D-3L). In a multivariable model, HIV 
status overall was not related to resilience. However, longer time diagnosed with HIV was related to lower resilience, and 
older age showed a non-significant trend towards higher resilience. In adults with HIV, high resilience was related to a lower 
prevalence of depression, anxiety, and problems with ADLs. It may be necessary to consider resilience when exploring the 
well-being of adults ageing with HIV.
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Introduction
Resilience is a multidimensional concept which seeks to 
explain how some individuals can attain, maintain, or regain 
well-being in the face of hardship [1]. It encompasses an 
individual’s current coping resources in response to stress-
ors, and their ability to effectively adapt these resources to 
manage new stressful situations [2–6]. Resilience can be 
broken down into five intrinsic characteristics: purpose/
meaning in life [7–9], perseverance [10], equanimity (bal-
ance, composure) [10, 11], self-reliance [1, 7, 8, 10, 12] 
and ‘authenticity’ (self-acceptance, autonomy) [7]. Often, 
definitions of resilience also rely on the premise that the 
individual has experienced stressful life events before and 
can utilise these experiences to effectively adapt their behav-
iours [13–15].
Higher levels of resilience have been consistently linked 
to improved mental and physical health in the general popu-
lation [16, 17]. This has been found in relation to chronic 
illness, health-care behaviours, and disability. Large longitu-
dinal studies have also provided evidence that resilience may 
be a protective factor against the development of disability, 
chronic illness, depression, or low Health-related Quality of 
Life (HrQoL) [18–20], suggesting a possible causal relation-
ship between high levels of resilience and overall well-being. 
Furthermore, many resilience studies focus on chronically 
ill populations, and have found evidence that it is possible to 
develop or maintain resilience despite poor physical health 
[19, 21, 22]. This implies that resilience can be used to 
improve well-being within chronically ill populations.
In the general population, older adults are consistently 
found to have high levels of resilience [20, 23, 24], which is 
thought to be due to accrued experiences with adversity—
such as bereavement, physical changes, and adaptive life 
roles [25]. Within people with HIV (PWH) it is possible that 
age, and increased time with diagnosed HIV, allow adults 
to learn and hone their coping strategies such that resilience 
increases. However it is also possible that illness-related 
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stress or poor mental health impairs this population’s abil-
ity to develop resilience in a manner similar to that of the 
toxic stress model [26], which states that prolonged stress 
and illness may inhibit the time and resources necessary for 
positive mental development. Research is required to iden-
tify the relationship between resilience and well-being in 
PWH by age and time diagnosed with HIV.
UNAIDS estimate that in high income countries 33.3% of 
PWH are over the age of 50 [27]. In the UK specifically, the 
number of older adults with HIV has tripled in the past dec-
ade [28], making older adults with HIV an important popu-
lation for researchers and clinicians to understand. A recent 
multicentre cross-sectional UK study (ASTRA) reported that 
longer time diagnosed with HIV was associated with poorer 
self-reported mental and physical health [29]. However, only 
two previous quantitative studies were identified in relation 
to HIV and resilience. The first compared resilience in peo-
ple with and without HIV (N = 60) using the CD-RISC scale 
[30]. This study found some evidence of lower resilience 
in PWH when compared to the HIV-negative group (mean 
score = 27.0 vs. 31.0, p = 0.06) [30]. The second study 
included 138 women with HIV in the USA, and found that 
high resilience was associated with increased antiretroviral 
therapy (ART) adherence and a greater likelihood of unde-
tectable HIV load, when controlled for age, race, income, 
substance use, and depressive symptoms [31]. Neither study 
explored the association between age and resilience in PWH, 
the association between resilience and time diagnosed with 
HIV, or the associations between resilience and physical 
or mental health in this population. As such, very little is 
known about the prevalence or importance of resilience in 
PWH.
The primary aims of this study were to (a) assess the 
association between HIV status and resilience, (b) assess the 
association of age with resilience in adults with and without 
HIV, (c) assess the association of ‘time with diagnosed HIV’ 
with resilience in adults with HIV and (d) assess the asso-
ciation of resilience with depression, anxiety, and problems 
with activities of daily living (ADLs) in adults with and 
without HIV.
Methods
The study aimed to recruit a group of PWH and a group of 
HIV-negative individuals. Individuals with diagnosed HIV 
attending the ambulatory care service at the Ian Charleson 
Centre (ICC) HIV clinic between March 2015 and August 
2015, and individuals with or without diagnosed HIV 
attending the Marlborough Sexual Health Clinic over the 
same period, were approached and invited to participate in 
the study. Both clinics are situated at the Royal Free Lon-
don NHS Foundation Trust, and provide HIV testing. The 
Marlborough clinic has high rates of HIV testing (99% offer 
and 86% uptake). Participants recruited from the Marlbor-
ough Clinic therefore reflect a population that are sexually 
active, but unlikely to have undiagnosed HIV infection.
Recruitment was done in specific clinical sessions within 
which all eligible patients were approached. All individuals 
who agreed to participate in the study gave written informed 
consent and completed a self-administered confidential pen-
and-paper questionnaire. Participants in the Marlborough 
Clinic were asked to self identify their HIV status at enrol-
ment (all reported they were HIV negative) and given the 
HIV positive, or negative, questionnaire as appropriate. The 
two versions of the questionnaire included identical items 
on a range of demographic, health, and lifestyle issues; the 
HIV-positive version also included an additional question 
relating to date of HIV diagnosis. The research protocol 
and all versions of the study documents (information sheet, 
consent form and questionnaire) were approved by the Lon-
don, Camden & Islington Research Ethics Committee (ref 
14.LO.1646).
Patients were eligible if they: (a) were over 18 years of 
age, (b) had sufficient English fluency to be able to under-
stand the information sheet, questionnaire and provide 
informed consent, and (c) were not too ill or distressed to 
participate, as judged by the clinic staff. In addition, HIV-
negative participants were further required to be aged 30 or 
over, to ensure a more comparable age distribution to that of 
the HIV positive population, as respondents from this clinic 
were found to be significantly younger than those from the 
HIV clinic in early data collection.
During the study period, 439 participants were invited to 
take part in the study, of which 327 completed the question-
naire (overall 74.5% response rate; 76% for HIV positive 
and 73% for HIV negative participants). No comparison data 
was available on the difference in demographics between 
respondents and non-respondents at either clinic.
Symptom Measures
The RS-14 [2] was used to measure resilience. This uses a 
14-item, 7-point Likert scale. The Resilience Scale (RS) [2] 
was specifically developed to measure resilience in older 
adults [25], and a recent systematic review concluded that 
the scale had ‘psychometric rigor’, as defined via an analy-
sis of content validity, internal consistency, criterion valid-
ity, construct validity, reproducibility, responsiveness, floor 
and ceiling effects and interpretability [32]. As such it was 
chosen for this study. The RS-14 scores are summed to cre-
ate a resilience reading (range 14–98). A summated score 
of ≥ 82 is taken to indicate high resilience; 74-81 indicates 
moderate resilience; and ≤ 73 indicates low resilience [10]. 
These are the accepted groupings for measuring resilience 
using this scale [10]. For the purpose of logistic regression 
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analysis participants reporting ‘high’ (scores ≥ 82) were 
compared to those reporting ‘moderate—low’ resilience 
scores (scores < 82).
Mental health was assessed using clinically validated 
questionnaire measures of depression and anxiety. Specifi-
cally, depression and anxiety symptoms were determined 
via self-report, using the PHQ-9 [33] and GAD-7 scales [34] 
respectively. These scales are validated diagnostic instru-
ments, based on the DSM-IV criteria for depression [33] and 
generalised anxiety disorder (GAD) [34]. Both scales inquire 
about the frequency of occurrence of specific symptoms in 
the past 2 weeks: the presence of depression and anxiety are 
defined according to standard algorithms based on a total 
score of 10 or more in each case. Binary variables were used 
as these were considered to have the most clinical relevance.
Difficulty with ADLs was identified using the EQ-5D 
[35], a five-item quality of life instrument. This instrument 
asks participants to report their ‘status of health today’ in 
relation to Mobility, Self-care, ‘Usual activities’ (e.g. work, 
study, housework, family, or leisure activities), Pain/discom-
fort and Anxiety/Depression. Response options comprise a 
five-point Likert scale. In this analysis, measures of diffi-
culty with ADLs were derived using the first three domains 
only. An overall measure of problems with physical func-
tion was used, where participants who reported problems 
(responses of ‘slight problems’, ‘moderate problems’, ‘severe 
problems’ or ‘unable to perform each activity’) in at least 
one of the three domains were classified as having a physical 
function problem. In addition, the three individual domains 
were also considered separately.
Other demographic factors included in the analysis were 
age group (< 40, 40–49, ≥ 50 years), self-reported gender/
sexuality (MSM, heterosexual men, women) and country 
of birth (UK-born or other). The age groups were chosen 
to coincide with the ‘older age’ group of ≥ 50 years which 
is commonly used in the HIV literature, and coincides with 
the age from which well-being is thought to improve in the 
general population [36], and to allow for the age restrictions 
imposed by necessity on the HIV negative participants.
Statistical Analysis
The distribution of the resilience score was examined among 
HIV-positive and HIV-negative samples, and means were 
compared using an unpaired t test. The association of HIV-
status with high resilience (score ≥ 82) was assessed using 
logistic regression analysis, adjusted for age group, gender/
sexual orientation and country of birth. Chi squared test for 
trend was used to assess the association of age group with 
resilience separately among HIV-positive and HIV-negative 
groups. Logistic regression was used to assess the adjusted 
associations of age group, gender/sexual orientation, and 
country of birth with high resilience (score ≥ 82) separately 
among the HIV-positive and HIV-negative groups. In addi-
tion, time since HIV diagnosis (< 5 years; 5–10 years; 
10–20 years and > 20 years) was included in the model for 
the HIV-positive group. Age and time since diagnosis of 
HIV (where appropriate) were fitted as categorical variables 
in logistic regression models in order to allow for non-linear 
patterns of association. Tests for linear trend across age and 
time with diagnosed HIV were also performed to identify 
linear differences in resilience and well-being across the 
HIV positive and negative groups. However, it was consid-
ered important to categorise age into groups, rather than 
as a continuous variable, to allow the exploration of non-
linear age differences. Age group, gender/sexual orientation, 
country of birth and time with diagnosed HIV were chosen 
as independent factors to include in the multivariable logis-
tic models, because these factors were considered potential 
confounders for which any causal association with resilience 
was likely to operate in one direction only.
The prevalence of depression, anxiety, and problems with 
ADLs (as defined above) were compared between HIV-posi-
tive and HIV-negative groups. The associations of resilience 
(categorised as low (RS-14 score ≤ 73), average (74–81), 
and high (≥ 82)) with depression, anxiety, and problems 
with ADLs, were assessed using Chi squared tests for trend 
for the HIV-positive and HIV-negative groups separately. 
Logistic regression analysis was used to identify the associa-
tion of age, gender/sexual orientation, country of birth, time 
with diagnosed HIV (for the HIV-positive group only) and 
resilience (categorised in three groups as defined above)with 
each of the three well-being measures (depression, anxiety, 
problems with ADLs) using two stages of analysis.
The initial analyses (Step 1) models included as inde-
pendent variables: age group, gender/sexuality, country of 
birth, and time since diagnosis of HIV (for the HIV-positive 
group only). The analyses were then rerun (Step 2) with the 
inclusion of resilience as an additional independent vari-
able (low-average (< 82); high (≥ 82)) in order to assess the 
extent to which resilience might ‘explain’ any associations of 
age and time with diagnosed HIV with depression, anxiety, 
or problems with ADLs.
Results
Subject Characteristics
The final HIV positive study population included 195 
participants. The HIV negative sample included 126 par-
ticipants. In the HIV positive group, the mean age was 
48 years (SD = 10.5, range 19–82 years). The mean age 
for the HIV negative population was 42 (SD = 11.2, range 
19–81) (Table 1). As such, the HIV positive population 
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Table 1  Demographic and 
health-related factors in the 
HIV- positive and HIV-negative 
samples (n & percentage of 
group)
a p < 0.001 Using Chi squared test for HIV-positive versus HIV-negative groups
Characteristics HIV positive population HIV nega-
tive popula-
tion
(N = 195) (N = 126)
Age (years)a
 Mean (SD) 48 (10.5) 42 (11.2)
 < 40 40 (20.5%) 68 (54.0%)
 40–50 72 (36.9%) 31 (24.6%)
 50–60 61 (31.3%) 17 (13.5%)
 60 + 22 (11.3%) 10 (7.9%)
Gender/sexualitya
 MSM 131 (66.5%) 30 (24.2%)
 Het. Male 27 (13.7%) 58 (46.8%)
 Female 39 (19.8%) 36 (29.0%)
Ethnicity
 Born in the UK 121 (61.7%) 72 (56.7%)
 White British 106 (54.1%) 49 (38.9%)
 Black African 32 (16.3%) 8 (6.3%)
Work  statusa
 Employed 114 (58.2%) 102 (81.6%)
 Unemployed 25 (12.8%) 5 (4.0%)
 Sick/disabled 28 (14.2%) 5 (4.0%)
 Retired 18 (9.2%) 4 (3.2%)
 Other 11 (5.6%) 9 (7.2%)
Highest education level
 University or above 106 (54.4%) 74 (60.7%)
 A levels 31 (15.9%) 18 (14.8%)
 GCSE/O-level 28 (14.4%) 11 (9.0%)
 None 24 (12.3%) 14 (11.5%)
Money for basic needs
 Always 114 (57.9%) 83 (66.4%)
 Mostly 49 (24.9%) 31 (24.8)
 Sometimes 18 (9.1%) 8 (6.4%)
 Never 16 (8.1%) 3 (2.4%)
Smoking status
 Current 58 (30.2%) 45 (36.0%)
 Ex-smoker 54 (28.1%) 23 (18.4%)
 Non-smoker 80 (41.7%) 57 (45.6%)
Recreational drug use (past 3 months)
 Yes 58 (29.6%) 26 (21.5%)
 No 138 (70.1%) 95 (78.5%)
 Time diagnosed with HIV
 0–5 years 32 (18.1%)
 5–10 years 32 (18.1%)
 10–20 years 61 (34.5%)
 20 + years 52 (2.4%)
Currently on ART
 Yes 171 (94.5%)
 No 24 (5.5%)
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was significantly older than the HIV negative population 
(p < 0.001), despite the recruitment measures used.
Of the HIV positive participants, 32 (18.1%) had 
been diagnosed with HIV for 0–5 years, 32 (18.1%) for 
5–10 years, 61 (34.5%) for 10–20 years and 52 (29.4%) for 
more than 20 years. The majority were currently on ART 
(N = 171, 94.5%). 89% of all PWH, and 93% of those using 
ART, had an undetectable plasma HIV load (< 40 HIV-1 
RNA copies/mL) at their last clinic visit.
There was a higher proportion of MSM in the HIV-pos-
itive compared to HIV negative group (66.5% vs. 24.2%; 
p < 0.001), and fewer heterosexual men (13.7% vs. 46.8%) 
and women (19.8% vs. 29.0%). PWH were more likely to be 
Black African (16.3% vs. 6.3%) than HIV negative partici-
pants, but there was no significant difference in ethnicity. 
No difference was observed in terms of levels of education, 
with similar proportions of HIV-positive and negative partic-
ipants attaining a university qualification (54.4% vs. 60.7%) 
and having no qualification (12.3% vs. 11.5%). However, 
PWH were less likely to be employed (58.1% vs. 81.6%), and 
more likely to be retired (9.2% vs. 3.2%) or not working due 
to sickness/disability (14.2% vs. 4.0%) than HIV-negative 
participants (p < 0.001). Despite this there was no substan-
tial difference in the number of participants who always had 
money for basic needs (57.9% vs. 66.4%).
There were no significant differences between the HIV-
positive and HIV-negative groups in relation to recreational 
drug use (29.6% vs. 21.5% respectively) or proportions who 
were current smokers (30.1% vs. 36.0%), ex-smokers (28.1% 
vs. 18.4%) or non-smokers (41.7% vs. 45.6%). These char-
acteristics are shown in Table 1.
Resilience
Within the entire study population (HIV-positive and HIV-
negative, N = 321), the mean resilience score was 76.9 
(SD = 17.7); corresponding to a rating of ‘moderate’ resil-
ience. The range was 14–98; the entire range of the RS-14 
scale. The mean RS-14 score was 76 (SD = 18.1) for HIV 
positive participants and 78.5 (SD = 16.5) for HIV negative 
participants, for which there was no significant difference 
(t = 1.25 (df = 319), p = 0.2). Resilience did not differ 
significantly by HIV status when adjusted for age, gender/
sexual orientation, and country of birth (adjusted Odds Ratio 
of high resilience, HIV positive reference group = 1.51, 95% 
CI 0.68–1.95, p = 0.61).
Table 2 reports the prevalence of resilience categorised 
by HIV status and age group. In unadjusted analysis, age 
group was not significantly associated with high resilience in 
either the HIV positive [χ2 test for trend, (N = 195) = 4.93, 
p = 0.55] or HIV negative groups [χ2, (N = 126) = 0.96, 
p = 0.99]. The adjusted association of age with high resil-
ience is presented in Table 3, for HIV positive and HIV-neg-
ative participants separately. Among HIV-positive partici-
pants (after adjustment for gender/sexuality, time diagnosed 
with HIV and country of birth) the proportion of subjects 
with high resilience tended to increase with older age (test 
for trend Odds ratio 1.52, CI 0.95–2.41, p = 0.08). Longer 
time diagnosed with HIV, on the other hand, was related 
to a decrease in the proportion with high resilience (test 
for trend Odds ratio 0.37, CI 0.14–0.98, p = 0.05). Among 
HIV-negative participants, there was no association between 
age and resilience. Country of birth and gender/sexual ori-
entation were not significantly associated with resilience in 
either group.
The Relationship Between Resilience and Mental 
and Physical Health
The presence of depression was reported by 39 (19.8%) HIV 
positive participants and 17 (13.1%) HIV negative partici-
pants. Anxiety was reported by 32 (16.2%) and 9 (6.9%) 
respectively and problems with ADLs by 69 (35.0%) and 
21 (16.2%) respectively. Compared to HIV-negative par-
ticipants, HIV-positive participants were significantly more 
likely to show the presence of anxiety [χ2, (N = 327) = 6.2, 
p = 0.009] and problems with ADLs [χ2, (N = 327) = 13.98, 
p  <  0.001], but not depression [χ2, (N  =  327)  =  2.5, 
p = 0.07].
The unadjusted associations of resilience with depression, 
anxiety, and ADL problems were assessed for adults with 
and without HIV, and are shown in Table 4. In PWH, high 
levels of resilience were found to be significantly related to 
lower prevalence of depression (6.7% vs. 36.5% for preva-
lence of depressive symptoms among participants with high 
vs. moderate - low resilience), anxiety (3.4% vs. 29.7% 
Table 2  Distribution of resilience score (RS-14 groupings) by age group and HIV status N (%)
Chi squared test for trend showed no significant difference (p = 0.2)
Age in years HIV positive (N = 195) HIV negative (N = 126)
Low (≤ 64) Average (65–81) High (≥ 82) Low (≤ 64) Average (65–81) High (≥ 82)
< 40 (N = 108) 20 (50.0%) 6 (15.0%) 14 (35.0%) 20 (29.4%) 16 (23.5%) 32 (47.1%)
40–50 (N = 103) 24 (33.3%) 11 (15.3%) 37 (51.4%) 7 (22.6%) 9 (29.0%) 15 (48.4%)
≥ 50 (N = 110) 29 (34.9%) 16 (19.3%) 38 (45.8%) 7 (25.9%) 6 (22.2%) 14 (51.9%)
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Table 3  Adjusted association of 
age, time with diagnosed HIV, 
gender/sexuality and country 
of birth with high resilience 
in HIV positive and negative 
adults (logistic regression 
analyses)
a Multivariable logistic regression models with high resilience (score ≥ 82) as the dependent variable and 
including all factors in table as independent variables. Separate models for HIV+ ve and HIV− ve groups. 
p‐values obtained using likelihood ratio tests
b Linear trend across groups
c Reference group
CI confidence intervals, MSM men who have sex with men
Independent Variable High resilience (score ≥ 82) High resilience (score ≥ 82)
p value Odds  ratioa 95% CI p value Odds  ratioa 95% CI
Age 0.11 0.78
Test for  trendb 0.08 1.52 (0.95, 2.41) 0.48 1.18 (0.75, 1.87)
< 40 0.05 0.37 (0.14, 0.98) 0.48 0.71 (0.28, 1.82)
40–50 0.82 0.92 (0.45, 1.88) 0.68 0.80 (0.27, 2.32)
50 + c 1 1
Years with diagnosed HIV 0.22
Test for trendb 0.05 0.37 (0.14, 0.98)
0–5c 1
5–10 0.89 0.93 (0.32, 2.65)
10–20 0.36 0.65 (0.26, 1.65)
20 + 0.07 0.38 (0.13, 1.08)
Gender/sexual orientation 0.64 0.54
MSMc 1 1
Hetero male 0.51 1.39 (0.51, 3.79) 0.30 1.64 (0.65, 4.13)
Female 0.41 1.41 (0.63, 3.15) 0.35 1.63 (0.59, 4.57)
Country of birth
Otherc 1 1
UK 0.92 0.96 (0.49, 1.89) 0.26 0.65 (0.31, 1.37)
Table 4  Physical and psychological symptom prevalence according to resilience level in adults with and without HIV
p Values by Chi squared test for trend
RS-14 score ≥ 82
a PHQ-9 score ≥ 10
b GAD-7 score ≥ 10
c Identified 1 or more problem on the first three questions of the EURO-QOL-5D
Resilience in adults with HIV
Low (score ≤ 73) Average (74–81) High (score ≥ 82) p value
(N = 74) (N = 34) (N = 89)
Depression  presenta 27 (36.5%) 6 (17.6%) 6 (6.7%) p < 0.001
Anxiety  presentb 22 (29.7%) 7 (20.6%) 3 (3.4%) p < 0.001
ADL  problemsc 39 (52.7%) 13 (38.2%) 17 (19.1%) p < 0.001
Resilience in adults without HIV
Low (score ≤ 73) Average (74–81) High (score ≥ 82) p value
(N = 35) (N = 27) (N = 64)
Depression  presenta 9 (25.7%) 3 (9.7%) 5 (7.8%) p = 0.03
Anxiety  presentb 4 (11.4%) 2 (6.5%) 3 (4.7%) p = 0.45
ADL  problemsc 9 (25.7%) 5 (16.1%) 7 (10.9%) p = 0.16
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respectively), and problems with ADLs (19.1% vs. 52.7% 
respectively; ps < 0.001, Chi squared tests). In adults with-
out HIV, the overall prevalence of depression, anxiety and 
problems with ADLs were lower. However similar trends 
were seen in terms of the association between these meas-
ures and resilience, although in the HIV-negative group this 
was statistically significant only for depression (7.8% vs. 
25.7%; for depression prevalence for high vs. moderate-low 
resilience p = 0.02).
Adjusted associations of age, gender/sexual orientation, 
country of birth, and time with diagnosed HIV with depres-
sion and anxiety symptoms are shown in Table 5 among 
HIV positive participants only. In adjusted analysis, in the 
first stage model which did not include resilience, there was 
evidence of trends towards lower depression (test for trend 
Odds ratio 0.6, CI 0.33–1.07, p = 0.08) and anxiety (test for 
trend Odds Ratio 0.51, CI 0.26–0.99, p = 0.05) with older 
age in HIV positive participants. Time diagnosed with HIV 
was not significantly related to depression in this sample, 
although there was a trend of higher prevalence of anxiety 
with longer time with diagnosed HIV (test for trend Odds 
Ratio 1.6, CI 0.98–2.61, p = 0.06). In the second stage of 
analysis, when resilience was included as an independent 
variable, the associations of younger age with depression 
and anxiety symptoms among the HIV-positive group were 
attenuated (test for trend Odds Ratios 0.72, CI 0.39–1.33, 
p = 0.29 and test for trend Odds Ratio 0.59, CI 0.28–1.20, 
p = 0.14 respectively). Similarly the association of time with 
diagnosed HIV with anxiety was attenuated when resilience 
was included in the model. (test for trend Odds Ratio 1.54, 
CI 0.90–2.66, p = 0.12). However, resilience was strongly 
and independently inversely associated with both depression 
and anxiety symptoms in the adjusted models (test for trend 
Odds Ratios 0.37, CI 0.23–0.62, p < 0.001 and test for trend 
Odds Ratio 0.35, CI 0.20–0.61, p < 0.001 respectively).
No association was found between age and problems 
with ADLs (test for trend Odds Ratio 0.96, CI 0.57–1.61, 
p = 0.88) in PWH in adjusted analyses (Table 5). Longer 
time with HIV diagnosis was strongly associated with 
increasing ADL prevalence (test for trend Odds Ratio 2.03, 
CI 1.35–3.03, p = 0.001). With the addition of resilience 
to the analysis, the associations were similar (test for trend 
Odds Ratio 1.93, CI 1.25–2.98, p = 0.003). However, resil-
ience itself was strongly inversely associated with problems 
with ADLs (test for trend Odds Ratio 0.47, CI 0.31–0.70, 
p < 0.001).
Discussion
Comparable levels of ‘high’ resilience (48.4% vs. 45.6%) 
were found in adults with and without HIV respectively in 
this study. In adults with HIV, there was evidence that older 
age, and shorter time with diagnosed HIV were associated 
with ‘high’ levels of resilience. Older age and shorter time 
with diagnosed HIV also tended to be associated with lower 
prevalence of psychological symptoms (as was found in an 
earlier study of people with HIV [29]). High resilience was 
found to be significantly inversely related to the prevalence 
of depression, anxiety, and ADL problems in this popu-
lation, and may, to some extent, mediate the relationship 
between age, time with diagnosed HIV, and mental health.
Resilience tended to increase with age, albeit nonsignifi-
cantly. While there is no literature available on age-related 
differences in resilience in PWH, resilience is thought to 
increase with age in the general population [7, 20, 23, 24, 39] 
in much the same way that well-being is found to increase 
from the age of 50 upwards [36]. In relation to resilience, 
this is possibly due to life experiences of coping with adver-
sity [25]. Were this to be the true, one might expect to see 
a stronger association between resilience and age in PWH 
as they are likely to have experienced a greater number of 
life stressors. This may be apparent in our results—whereby 
an age-related association with resilience was suggested in 
the HIV positive population only. However, this data was 
under-powered to detect this, as the majority (54%) of HIV 
negative participants were under the age of 40. Despite this, 
in PWH the relationships of age and time diagnosed with 
HIV with depression and anxiety became weaker once resil-
ience was included in the model. This gives some suggestion 
that high resilience may in part ‘explain’ why those who 
were older had lower prevalence of psychological symptoms. 
As resilience was also found to be related to better men-
tal health, this may partially explain the results identified 
through the larger, multi-centre ASTRA study [29] which 
showed more favourable mental health with older age in UK 
PWH despite lower levels of physical health.
In contrast to age, longer time with diagnosed HIV was 
related to a decrease in the proportion of subjects with high 
resilience scores and an increase in problems with ADLs. 
Adults who have lived with HIV for prolonged periods of 
time, and especially through the period prior to development 
of combination ART (when HIV was viewed as a terminal 
illness), may have experienced a continued accumulation 
of stressors related to illness, stigma, and ageing with HIV, 
which could prevent them from developing resilience. In 
other words, similar to the toxic stress model [26], prolonged 
ill health and stress may inhibit the development of positive 
mental responses in PWH by restricting the resources neces-
sary to cope with stress. This would result in low resilience 
in adults diagnosed with HIV for a long time, which could 
then exacerbate physical and mental stress. Resilience may 
therefore explain (at least in part) the higher levels of depres-
sion and anxiety reported in long-term diagnosed PWH 
[29] and resilience-based interventions could be considered 
within this sub-population in order to improve well-being. 
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This may lead to improved outcomes as resilience has been 
related to medication adherence [31], and may well relate 
to engagement in care, both of which are important to the 
life-long treatment of complex chronic illnesses. Such inter-
ventions have been piloted amongst patients with diabetes 
[40], for example, with positive results.
Two previous studies have reported high levels of depres-
sion among people with HIV [29, 41], which was supported 
by the results presented here, but none have assessed the 
association of mental health with resilience in adults ageing 
with HIV. In the present study, high resilience was signifi-
cantly related to lower prevalence of symptoms of depres-
sion and anxiety in PWH and lower prevalence of problems 
with ADLs. While no previous studies have explored the 
relationship between resilience and well-being in an HIV 
positive population, resilience has been consistently linked 
to mental [16, 20] and physical health [17–19] and health-
care activities [22, 42, 43] in the general population. A pos-
sible reason for this is that resilient individuals are more 
‘self-reliant’ [7, 8, 10] and perseverant [10] and may be 
more likely to engage in health-promoting behaviours such 
as healthy eating and exercise [43] which, in turn, improves 
overall mental and physical health. High levels of resilience 
may also buffer adults against mental distress by allowing for 
the development of adaptive coping mechanisms [4, 5, 44]. 
From the data presented here, it appears that high levels of 
resilience are related to improved mental and physical well-
being in the HIV positive population.
One previous study has compared resilience by HIV sta-
tus, and also reported somewhat lower levels of resilience 
in PWH compared to people without, but the comparison 
was not significant [30]. Our results are similar to these in 
that overall, HIV status was not significantly associated with 
resilience. It is possible, therefore, that HIV does not affect 
resilience in the same way as other chronic illnesses [19, 22]. 
This could be due to the large amount of support available to 
PWH through their HIV clinic [37, 38], which could enable 
positive mental well-being. However, the results relating to 
time diagnosed with HIV do not support this suggestion. 
Time with diagnosed HIV was inversely associated with 
high resilience, and those who have been diagnosed with 
HIV for longer would potentially have received more sup-
port [38], but showed lower levels of resilience. However, 
the limitations present in early HIV care and medication may 
have counteracted any such support. As both the previous 
[30] and current study utilised small sample sizes, it is also 
possible that there is a genuine difference in resilience scores 
according to HIV-status, but that a larger study is necessary 
in order to identify this difference. Previous studies have 
suggested that it is possible to develop or maintain resilience 
despite poor physical health [19, 21, 22]. Several studies 
have also suggested a causal relationship between resilience 
and well-being [18–20]. As resilience was not found to be Ta
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significantly associated with HIV status, but was related to 
mental and physical health within our population, it may be 
possible to improve mental and physical well-being in adults 
with HIV through a resilience-based intervention.
Limitations
There are limitations to this analysis. The HIV-negative 
group may have included a small number of individuals with 
undiagnosed HIV (those who had declined HIV-testing, or 
who tested positive subsequent to completion of the ques-
tionnaire). This may have impacted the mental and physical 
health scores reported in the HIV-negative group. How-
ever, the life experiences of those undiagnosed with HIV 
are likely to be different to those diagnosed and undergoing 
treatment. As such we consider them to be a distinct and 
separate group to PWH.
The sample size of older HIV-negative participants was 
small due to the lack of older adults attending the GUM 
clinic, which resulted in lack of power for age-related com-
parisons, as shown in the width of the confidence intervals 
reported. Due to the sample size we were required to com-
bine all adults over the age of 50 into one group, preventing 
further analysis within the older adult population. The small 
sample size also limited the power of this study and may 
have resulted in type two errors.
The sample size also prevented us from performing 
sub-group analysis in relation to gender or ethnicity, or 
interaction tests. As significant differences were found in 
the proportion of participants by gender/sexual orientation 
between the HIV positive and negative groups, this may have 
impacted the HIV status group comparisons. However, as 
there was no significant association found between resilience 
and gender/sexual orientation, we do not consider this to be 
a major limitation.
It is also important to note that the associations reported 
are only correlational and, while causal explanations have 
been suggested, longitudinal data is required to provide 
stronger evidence of causality. As with any single-site study, 
the generalisability of these findings to other populations is 
currently unknown.
Conclusions and Implications
This study provides the first data on resilience among PWH 
in the UK, and the associations of resilience with age and 
time with diagnosed HIV. It is the first to explore the rela-
tionship between mental and physical well-being with resil-
ience in adults with HIV, and one of the first to explore 
resilience in comparison to HIV negative adults. The results 
suggest that, while resilience appears to increase with age, it 
appears to decline with increasing time diagnosed with HIV. 
As resilience was found to be inversely related to the preva-
lence of depression, anxiety, and physical health problems, it 
may mediate the associations of age and time with diagnosed 
HIV with mental health. Furthermore, resilience was not 
associated with HIV status overall, suggesting that it is pos-
sible to develop resilience within this population. Resilience 
and potential interventions to improve resilience are likely, 
therefore, to become increasingly important as the HIV posi-
tive population ages, and may have important implications 
for the care of HIV positive people in the future.
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